本文選題：鼻內鏡 + 淚囊鼻腔黏膜吻合術��； 參考：《中國現代醫(yī)學雜志》2017年20期

【摘要】：目的探討曲安奈德聯合淚道置管在鼻內鏡下淚囊鼻腔黏膜吻合術(EE-DCR)的治療效果。方法選擇40例(42眼)慢性淚囊炎患者行EE-DCR聯合淚道置管,明膠海綿片局部覆蓋淚囊鼻腔吻合瓣,表面注射40 mg/ml曲安奈德浸潤術腔。1周后鼻腔清理,1個月后取出淚道置管。結果分別于術后1個月、6個月和1年行鼻內鏡檢查及淚道沖洗。術后1個月治療好轉率為100%,術后6個月為95.2%;術后1年為92.9%。所有患者未發(fā)生眶內損傷、鼻腔出血等術后并發(fā)癥。結論 EE-DCR中應用曲安奈德聯合淚道置管治療可有效提高手術成功率,是一種有效、微創(chuàng)、安全的手術方法。
[Abstract]:Objective to evaluate the efficacy of triamcinolone acetonide combined with lacrimal duct placement in endoscopic dacryocystorhinostomy (EE-DCRs). Methods 40 cases (42 eyes) of chronic dacryocystitis were treated with EE-DCR combined with lacrimal duct tube. The dacryocystorhinostomy flap was partially covered by gelatin sponge film. The nasal cavity was cleaned after injection of 40 mg/ml triamcinolone acetonide for 1 week and the lacrimal duct was removed after 1 month. Results nasal endoscopy and lacrimal passage irrigation were performed 1 month, 6 months and 1 year postoperatively. The improvement rate was 100% in one month, 95.2 in 6 months after operation, and 92.9 in one year after operation. No intraorbital injury, nasal hemorrhage and other postoperative complications occurred in all patients. Conclusion Triamcinolone acetonide combined with lacrimal duct placement in EE-DCR is an effective, minimally invasive and safe method to improve the successful rate of operation.
【作者單位】： 中南大學湘雅醫(yī)院;
【分類號】：R779.6
，

本文編號：1816432